Mission Bio Company
Leading precision medicine with the only single-cell multi-omics platform integrating genotype and phenotype
Investors
.jpg)
.jpg)
.jpg)
.jpg)
Technology:
Non-clinical Applications
Industry:
AI for Longevity
Headquarters:
Others
Founded Date:
2012-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
12
Total Funding:
$110.1M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Series C
Register and Claim Ownership